| Malignant Pancreatic Neoplasm predicts response to …PREDICTS_RESPONSE_TO29 of 29show fewer |
|---|
| in context · predicts response to | BRCA1 Mutationother → predicts response to Cisplatin 2 source records aggregated | sensitivity | B | Malignant Pancreatic Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | RRM1 Underexpressionexpression → predicts response to Gemcitabine 2 source records aggregated | sensitivity | B | Malignant Pancreatic Neoplasm | 2 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Pertuzumab | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | ERBB2 Amplificationamplification → predicts response to Trastuzumab | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Cisplatin | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Gemcitabine | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Veliparib | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Gemcitabine | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Veliparib | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Platinum Compound | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA1 Mutationother → predicts response to Oxaliplatin | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Olaparib | sensitivity | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Exon 2 MutationSNV → predicts response to Erlotinib | resistance | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | KRAS Exon 2 MutationSNV → predicts response to Gemcitabine | resistance | B | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF Fusionfusion → predicts response to Vemurafenib | sensitivity | C | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | STK11 D194ESNV → predicts response to Everolimus | sensitivity | C | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRAF N486_P490deldeletion → predicts response to Trametinib | sensitivity | C | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Mutationother → predicts response to Iniparib | sensitivity | C | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | PALB2 Biallelic Inactivation → predicts response to Mitomycin | sensitivity | C | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | SIRT1 Overexpressionexpression → predicts response to Niacinamide | resistance | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | RRM2 OVEREXPRESSIONexpression → predicts response to Gemcitabine | resistance | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | RRM1 Overexpressionexpression → predicts response to Gemcitabine | resistance | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | BRCA2 Loss-of-function → predicts response to Mitomycin | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FANCC Loss-of-function → predicts response to Gemcitabine | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FANCC Loss-of-function → predicts response to Chlorambucil | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FANCC Loss-of-function → predicts response to Melphalan | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FANCC Loss-of-function → predicts response to Cisplatin | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |
| in context · predicts response to | FANCC Loss-of-function → predicts response to Mitomycin | sensitivity | D | Malignant Pancreatic Neoplasm | 1 | Curated | civic | graph → |